Incyte Corp
INCY- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0000879169
In the last 90 days, Incyte Corp insiders filed 0 open-market purchases and 10 sales; 860 institutions reported holding it in 13F filings for Q2 2026, worth $23.0B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Incyte Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 10 filings
- 4 insiders, $18.2M in total
- Insiders trading
- 4
- Net value
- −$18.2M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Incyte Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Gardner David H | EVP, Chief Strategy Officer | 15,904 | Sep 24, 2026 | 2 |
| Cagnoni Pablo J | President, Global Head of R&D | 183,200 | Sep 17, 2026 | 13 |
| Basi Ramitpal K | EVP, Human Resources | 10,993 | Aug 27, 2026 | 2 |
| Mayes Patrick A | EVP & Chief Scientific Officer | 61,441 | Aug 7, 2026 | 8 |
| Morrissey Michael James | EVP, Head of Tech. Operations | 34,065 | Jul 27, 2026 | 6 |
| Heeson Lee | EVP, Head of Incyte Intl | 38,041 | Jul 27, 2026 | 5 |
| Tray Thomas | Principal Accounting Officer | 21,699 | Jul 20, 2026 | 8 |
| Stein Steven H | CMO & Head of Late-Stage Dev. | 30,916 | Jul 20, 2026 | 9 |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | 71,797 | Jul 20, 2026 | 4 |
| Hoffman Richard A. | EVP & General Counsel | 16,861 | Jul 20, 2026 | 2 |
| Meury William | Chief Executive Officer | 183,129 | Jul 20, 2026 | 3 |
| Baker Julian | Director, 10% Owner | 28,205,760Indirect | Jul 2, 2026 | 6 |
| Baker Felix | Director, 10% Owner | 28,205,760Indirect | Jul 2, 2026 | 6 |
| Baker Bros. Advisors LP | Director, 10% Owner | 28,205,760Indirect | Jul 2, 2026 | 6 |
| Baker Brothers Life Sciences LP | Director, 10% Owner | 28,205,760Indirect | Jul 2, 2026 | 6 |
| 667, L.P. | Director, 10% Owner | 28,205,760Indirect | Jul 2, 2026 | 6 |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | 28,205,760Indirect | Jul 2, 2026 | 6 |
| Clancy Paul J | Director | 25,635 | Jul 2, 2026 | 6 |
| Harrigan Edmund | Director | 23,019 | Jul 2, 2026 | 5 |
| Brawley Otis W | Director | 12,894 | Jun 10, 2026 | 1 |
| Bienaime Jean Jacques | Director | 24,424 | Jun 10, 2026 | 2 |
| Fouse Jacqualyn A | Director | 20,968 | Jun 10, 2026 | 1 |
| High Katherine A | Director | 14,983 | Jun 10, 2026 | 1 |
| Upadhyay Suketu | EVP & Chief Financial Officer | 26,343 | May 6, 2026 | 1 |
| Trotta Matteo | EVP, GM, Dermatology US | 14,882 | Mar 26, 2026 | 2 |
| Hoppenot Herve | Director | 326,803 | Dec 10, 2025 | 2 |
| Denton Sheila A. | EVP & General Counsel | 26,569 | Nov 19, 2025 | 4 |
| Flannelly Barry P | EVP & General Manager US | 35,149 | Jul 17, 2025 | 0 |
| Iyengar Vijay K | EVP, GMAPPS | 40,540 | Jul 17, 2025 | 0 |
| Swain Paula J | EVP, Human Resources | 106,482 | Jul 16, 2025 | 0 |
| Stamoulis Christiana | EVP & Chief Financial Officer | 125,759 | Jul 16, 2025 | 0 |
| Schaffert Susanne | Director | 7,389 | Jun 12, 2025 | 0 |
| Dickinson Jonathan Elliott | EVP, General Manager, Europe | 36,390 | Sep 16, 2024 | 0 |
| Pasquale Maria E | EVP & General Counsel | 69,724 | Jul 18, 2023 | 0 |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 58,968 | Jul 18, 2023 | 0 |
| Dixon Wendy L | Director | 17,768 | Apr 4, 2022 | 0 |
| Trower Paul | Principal Accounting Officer | 32,268 | Jan 21, 2022 | 0 |
| Wenqing Yao | EVP, Head of Discovery Chem | 98,575 | Jul 7, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 (view filing) | Dec 13-16 | 4 days | Tray ThomasPrincipal Accounting Officer | SSale | −1.30K | $69.98 | −$91.0K | −5.3%23.3K after | 2 lots10b5-1 |
| Dec 3, 2024 (view filing) | Nov 29 | 4 days | Iyengar Vijay KEVP, GMAPPS | SSale | −6.04K | $75.38 | −$455.5K | −16.5%30.7K after | 2 lots10b5-1 |
| Nov 8, 2024 (view filing) | Nov 6 | 2 days | Flannelly Barry PEVP & General Manager US | SSale | −3.68K | $79.68 | −$293.2K | −6.0%58.0K after | 2 lots10b5-1 |
| Sep 16, 2024 (view filing) | Sep 12-13 | 4 days | Tray ThomasPrincipal Accounting Officer | SSale | −954 | $63.11 | −$60.2K | −3.8%24.4K after | 2 lots10b5-1 |
| Sep 16, 2024 (view filing) | Sep 12 | 4 days | Dickinson Jonathan ElliottEVP, General Manager, Europe | SSale | −8.45K | $62.36 | −$526.9K | −18.8%36.4K after | 2 lots10b5-1 |
| Aug 14, 2024 (view filing) | Aug 12 | 2 days | Stein Steven HEVP & Chief Medical Officer | SSale | −11.6K | $60.63 | −$703.8K | −11.4%90.0K after | 10b5-1 |
| Jul 29, 2024 (view filing) | Jul 25 | 4 days | Iyengar Vijay KEVP, GMAPPS | SSale | −15.6K | $70.00 | −$1.09M | −29.8%36.7K after | 10b5-1 |
| Jul 17, 2024 (view filing) | Jul 16 | 1 day | Flannelly Barry PEVP & General Manager US | SSale | −1.31K | $64.19 | −$83.8K | −2.2%58.0K after | 10b5-1 |
| Jul 11, 2024 (view filing) | Jul 9 | 2 days | Flannelly Barry PEVP & General Manager US | SSale | −8.15K | $60.00 | −$488.9K | −13.9%50.5K after | 10b5-1 |
| Jun 14, 2024 (view filing) | Jun 12 | 2 days | Flannelly Barry PEVP & General Manager US | SSale | −19.2K | $60.00 | −$1.15M | −22.4%66.4K after | 10b5-1 |
| Jun 10, 2024 (view filing) | Jun 6 | 4 days | Tray ThomasPrincipal Accounting Officer | SSale | −1.09K | $58.91 | −$64.4K | −4.8%21.6K after | 10b5-1 |
| Jan 5, 2024 (view filing) | Jan 3 | 2 days | Stein Steven HEVP & Chief Medical Officer | SSale | −7.37K | $65.51 | −$482.5K | −7.5%90.2K after | 10b5-1 |
| Jan 4, 2024 (view filing) | Jan 2 | 2 days | Iyengar Vijay KEVP, GMAPPS | SSale | −657 | $65.00 | −$42.7K | −1.5%43.4K after | 10b5-1 |
| Dec 14, 2023 (view filing) | Dec 12-13 | 2 days | Tray ThomasPrincipal Accounting Officer | SSale | −1.28K | $61.55 | −$78.6K | −5.2%23.4K after | 2 lots10b5-1 |
| Sep 6, 2023 (view filing) | Sep 1 | 5 days | Swain Paula JEVP, Human Resources | SSale | −8.45K | $65.13 | −$550.3K | −9.8%77.5K after | |
| Aug 3, 2023 (view filing) | Aug 1 | 2 days | Stein Steven HEVP & Chief Medical Officer | SSale | −21.5K | $63.28 | −$1.36M | −18.1%97.6K after | 10b5-1 |
| Feb 2, 2023 (view filing) | Jan 31 | 2 days | Pasquale Maria EEVP & General Counsel | SSale | −802 | $84.06 | −$67.4K | −1.2%68.5K after | |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Pasquale Maria EEVP & General Counsel | SSale | −60.0K | $84.74 | −$5.09M | −46.7%68.5K after | 6 lots |
| Jan 30, 2023 (view filing) | Jan 26 | 4 days | Iyengar Vijay KEVP, GMAPPS | SSale | −7.00K | $85.00 | −$595.0K | −14.0%42.8K after | |
| Jan 30, 2023 (view filing) | Jan 26 | 4 days | Dhanak DashyantEVP & Chief Scientific Officer | SSale | −2.42K | $85.00 | −$205.6K | −4.3%53.3K after | |
| Jan 6, 2023 (view filing) | Jan 4 | 2 days | Stein Steven HEVP & Chief Medical Officer | SSale | −28.4K | $79.78 | −$2.27M | −20.7%109.0K after | |
| Dec 28, 2022 (view filing) | Dec 23 | 5 days | Iyengar Vijay KEVP, GMAPPS | SSale | −17.3K | $80.80 | −$1.40M | −31.4%37.9K after | 4 lots |
| Dec 21, 2022 (view filing) | Dec 19 | 2 days | Tray ThomasPrincipal Accounting Officer | SSale | −1.22K | $82.16 | −$100.5K | −6.9%16.6K after | |
| Jul 26, 2022 (view filing) | Jul 22 | 4 days | Tray ThomasPrincipal Accounting Officer | SSale | −1.56K | $83.13 | −$130.0K | −8.1%17.7K after | |
| Jul 11, 2022 (view filing) | Jul 7 | 4 days | Iyengar Vijay KEVP, GMAPPS | SSale | −5.79K | $79.38 | −$459.4K | −12.6%40.3K after | |
| Jul 11, 2022 (view filing) | Jul 7 | 4 days | Flannelly Barry PEVP & General Manager US | SSale | −2.87K | $79.38 | −$228.1K | −3.8%72.7K after | |
| Apr 12, 2022 (view filing) | Apr 8 | 4 days | Flannelly Barry PEVP & General Manager US | SSale | −44.0K | $83.49 | −$3.67M | −40.3%65.2K after | 4 lots |
| Mar 10, 2022 (view filing)6:02 PM ET | Mar 8-10 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +389.1K | $72.24 | +$28.1M | +1.2%33.4M after | 10 lots |
| Feb 22, 2022 (view filing)5:45 PM ET | Feb 17-22 | 5 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +525.8K | $67.96 | +$35.7M | +1.6%33.0M after | 8 lots |
| Feb 14, 2022 (view filing)5:23 PM ET | Feb 10-14 | 4 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +1.60M | $66.91 | +$107.0M | +5.2%32.5M after | 7 lots |
| Feb 2, 2022 (view filing) | Jan 31 | 2 days | Dickinson Jonathan ElliottEVP, General Manager, Europe | SSale | −7.38K | $74.19 | −$547.2K | −19.6%30.2K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Swain Paula JEVP, Human Resources | SSale | −10.9K | $73.31 | −$796.9K | −13.1%72.4K after | |
| Jan 5, 2022 (view filing) | Jan 3 | 2 days | Trower PaulPrincipal Accounting Officer | SSale | −8.21K | $73.31 | −$602.2K | −20.3%32.3K after | 2 lots |
| Jan 5, 2022 (view filing) | Jan 4 | 1 day | Swain Paula JEVP, Human Resources | SSale | −9.32K | $73.46 | −$684.6K | −11.4%72.4K after | |
| Dec 27, 2021 (view filing) | Dec 23 | 4 days | Dixon Wendy LDirector | SSale | −20.0K | $22.05 | −$441.0K | −53.7%17.3K after | |
| Dec 17, 2021 (view filing)6:30 PM ET | Dec 15-17 | 2 days | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +1.60M | $72.43 | +$115.6M | +5.4%30.9M after | 10 lots |
| Oct 4, 2021 (view filing) | Oct 1 | 3 days | Dhanak DashyantEVP & Chief Scientific Officer | SSale | −389 | $68.67 | −$26.7K | −1.2%31.3K after | |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Dhanak DashyantEVP & Chief Scientific Officer | SSale | −388 | $76.71 | −$29.8K | −1.2%31.7K after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Dhanak DashyantEVP & Chief Scientific Officer | SSale | −389 | $77.49 | −$30.1K | −1.2%32.0K after | |
| Aug 2, 2021 (view filing) | Jul 29 | 4 days | Iyengar Vijay KEVP GPS, BD, & Licensing | SSale | −4.91K | $78.29 | −$384.5K | −15.4%27.0K after | |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Dhanak DashyantEVP & Chief Scientific Officer | SSale | −396 | $84.09 | −$33.3K | −1.5%26.1K after |